What Is IDXX Fair Value?
Idexx Laboratories (IDXX) fair value estimate using multiple valuation models, updated daily.
As of August 29, 2026, Idexx Laboratories (IDXX) has a composite fair value estimate of $174.22 based on four valuation models: DCF (41% weight), Graham Number (29% weight), PEG (29% weight), and DDM (0% weight). The current market price is $554.99, suggesting the stock is overvalued by 68.6%.
Data as of August 29, 2026 (today)
Composite Fair Value
Overvalued3 of 4 models$174.22
vs. current price of $554.99(-68.6%)
How Is IDXX Fair Value Calculated?
Four independent models estimate what IDXX is worth. Each uses different inputs and assumptions. The composite blends them by weight.
IDXX Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
41% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$191.23
-65.5%Overvalued
Inputs used
DDM (Dividend Discount Model)
0% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
N/A
This stock does not pay a dividend, so the DDM cannot be applied. The composite adjusts by redistributing this weight to the other models.
IDXX Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
29% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$82.61
-85.1%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
29% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$194.78
-64.9%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $554.99 is 65.5% above this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $1.03B | $912.3M |
| Year 2 | $1.16B | $915.3M |
| Year 3 | $1.32B | $918.3M |
| Year 4 | $1.49B | $921.3M |
| Year 5 | $1.69B | $924.4M |
| Year 6 | $1.91B | $927.4M |
| Year 7 | $2.16B | $930.4M |
| Year 8 | $2.44B | $933.5M |
| Year 9 | $2.76B | $936.5M |
| Year 10 | $3.12B | $939.6M |
| Terminal Value | $31.19B | $9.39B |
What Are IDXX's Key Financial Metrics?
Earnings & Growth
Current Price
$554.99
EPS (TTM)
$14.49
Forward P/E
33.2
Profit Margin
25.0%
Cash & Balance Sheet
Free Cash Flow
909.4M
EBITDA
1.6B
Book Value
$20.45
Total Debt
1.1B
What Do Analysts Say About IDXX?
Low
$470.00
Average
$698.92
High
$805.00
Upside
+25.9%
IDXX Fair Value FAQ
What is the fair value of IDXX?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), IDXX's estimated fair value is $174.22. The stock is currently trading at $554.99, which makes it overvalued by our analysis.
How is IDXX's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is IDXX overvalued or undervalued?
Based on our analysis, IDXX is overvalued. The current price of $554.99 is 68.6% above our estimated fair value of $174.22.
What do Wall Street analysts say about IDXX?
13 analysts cover Idexx Laboratories with a consensus rating of "Buy." The average price target is $698.92, ranging from $470.00 to $805.00. This implies 25.9% upside from the current price.